These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9309158)

  • 1. [Angiogenesis and its inhibitors].
    Ono M; Kuwano M
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1585-93. PubMed ID: 9309158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer drug targets: approaching angiogenesis.
    Keshet E; Ben-Sasson SA
    J Clin Invest; 1999 Dec; 104(11):1497-501. PubMed ID: 10587512
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of angiogenesis in the treatment of tumors.
    Ostrowski K; Kinsner A
    Arch Immunol Ther Exp (Warsz); 2001; 49(1):27-31. PubMed ID: 11266087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic prospects of angiogenesis inhibitors in cancerology].
    Bout JC; Soncin F; Vandenbunder B
    Rev Mal Respir; 1999 Nov; 16(5):854-5. PubMed ID: 10612161
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiogenesis and surgery: from mice to man.
    Drixler TA; Voest EE; van Vroonhoven TJ; Borel Rinkes IH
    Eur J Surg; 2000 Jun; 166(6):435-46. PubMed ID: 10890539
    [No Abstract]   [Full Text] [Related]  

  • 6. [Research on the endothelium and new therapeutic strategies in tumors and cardiovascular diseases].
    Dejana E
    Recenti Prog Med; 1999 Feb; 90(2):64-8. PubMed ID: 10208094
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiogenesis: the unifying concept in cancer?
    Saphir A
    J Natl Cancer Inst; 1997 Nov; 89(22):1658-9. PubMed ID: 9390530
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antiangiogenic therapy].
    Toi M
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2003-9. PubMed ID: 9838900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis and antiangiogenic therapy.
    Sledge GW; Miller KD
    Curr Probl Cancer; 2002; 26(1):1-60. PubMed ID: 11961506
    [No Abstract]   [Full Text] [Related]  

  • 10. [Angiostatin. A biological inhibitor of tumor angiogenesis].
    Thimme R; Spangenberg HC; Blum HE
    Dtsch Med Wochenschr; 1997 Mar; 122(13):413-4. PubMed ID: 9138915
    [No Abstract]   [Full Text] [Related]  

  • 11. [The clinical perspective of angiogenesis inhibitors].
    Radema SA; Witteveen PO; Gebbink MB; Voest EE
    Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1675-80. PubMed ID: 14513538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis.
    Yamakawa S; Asai T; Uchida T; Matsukawa M; Akizawa T; Oku N
    Cancer Lett; 2004 Jul; 210(1):47-55. PubMed ID: 15172120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of angiogenesis enter phase III testing.
    Nelson NJ
    J Natl Cancer Inst; 1998 Jul; 90(13):960-3. PubMed ID: 9665141
    [No Abstract]   [Full Text] [Related]  

  • 14. Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase.
    Kim YM; Jang JW; Lee OH; Yeon J; Choi EY; Kim KW; Lee ST; Kwon YG
    Cancer Res; 2000 Oct; 60(19):5410-3. PubMed ID: 11034081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis and cancer: recent advances.
    Cáceres W; González S
    P R Health Sci J; 2003 Jun; 22(2):149-51. PubMed ID: 12866139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A fragment of collagen XVIII inhibits angiogenesis].
    Zätterström UK; Fukai N; Olsen BR
    Tidsskr Nor Laegeforen; 2000 Nov; 120(29):3547-50. PubMed ID: 11188382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cancer therapy resistant to resistance.
    Kerbel RS
    Nature; 1997 Nov; 390(6658):335-6. PubMed ID: 9389468
    [No Abstract]   [Full Text] [Related]  

  • 18. Optical imaging and tumor angiogenesis.
    Lin PC
    J Cell Biochem; 2003 Oct; 90(3):484-91. PubMed ID: 14523982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
    Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
    Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis.
    Pozzi A; LeVine WF; Gardner HA
    Oncogene; 2002 Jan; 21(2):272-81. PubMed ID: 11803470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.